Agios Pharma (AGIO) Misses Q2 EPS by 22c

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.78), $0.22 worse than the analyst estimate of ($1.56). Revenue for the quarter came in at $11.35 million versus the consensus estimate of $9.62 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance